PL2731597T3 - Sposoby leczenia stanu zapalnego i nadciśnienia tętniczego za pomocą wychwytywaczy gamma-ketoaldehydowych - Google Patents
Sposoby leczenia stanu zapalnego i nadciśnienia tętniczego za pomocą wychwytywaczy gamma-ketoaldehydowychInfo
- Publication number
- PL2731597T3 PL2731597T3 PL12811030.1T PL12811030T PL2731597T3 PL 2731597 T3 PL2731597 T3 PL 2731597T3 PL 12811030 T PL12811030 T PL 12811030T PL 2731597 T3 PL2731597 T3 PL 2731597T3
- Authority
- PL
- Poland
- Prior art keywords
- skavengers
- ketoaldehyde
- hypertension
- gamma
- methods
- Prior art date
Links
- 206010020772 Hypertension Diseases 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/50—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161506848P | 2011-07-12 | 2011-07-12 | |
| PCT/US2012/046549 WO2013010034A2 (en) | 2011-07-12 | 2012-07-12 | Methods for treating inflammation and hypertension with gamma-ketoaldehyde skavengers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2731597T3 true PL2731597T3 (pl) | 2024-04-29 |
Family
ID=47506934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12811030.1T PL2731597T3 (pl) | 2011-07-12 | 2012-07-12 | Sposoby leczenia stanu zapalnego i nadciśnienia tętniczego za pomocą wychwytywaczy gamma-ketoaldehydowych |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US10975033B2 (pl) |
| EP (1) | EP2731597B1 (pl) |
| JP (1) | JP6280033B2 (pl) |
| KR (2) | KR20140050661A (pl) |
| CN (2) | CN103796648B (pl) |
| AU (1) | AU2012281061B2 (pl) |
| BR (1) | BR112014000810A8 (pl) |
| CA (1) | CA2844150C (pl) |
| ES (1) | ES2970814T3 (pl) |
| HU (1) | HUE065757T2 (pl) |
| MX (1) | MX383365B (pl) |
| PL (1) | PL2731597T3 (pl) |
| WO (1) | WO2013010034A2 (pl) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130018478A (ko) * | 2011-08-09 | 2013-02-25 | 주식회사 엘지화학 | 신규한 구조의 이차전지 팩 |
| US10166248B1 (en) * | 2015-12-21 | 2019-01-01 | Vanderbilt University | Methods of preventing platelet activation |
| US11400103B2 (en) | 2015-12-21 | 2022-08-02 | Vanderbilt University | Methods of preventing platelet activation |
| MX2019000114A (es) * | 2016-07-06 | 2019-04-01 | Univ Vanderbilt | Uso de neutralizadores de gama-cetoaldehidos reactivos para prolongar la vida util de la celula y el ciclo sano. |
| BR112019000251A2 (pt) * | 2016-07-07 | 2019-04-16 | Vanderbilt University | prevenção e tratamento de fibrilação/flutter atrial com sequestrantes de gama-cetoaldeído |
| MX2019002579A (es) * | 2016-09-06 | 2020-02-05 | Metabolic Tech Inc | Composiciones y metodos de uso de depuradores de gamma-cetoaldehido para tratar, evitar o mejorar la enfermedad del higado graso no alcoholico (nafld), nash, ald o condiciones relacionadas al higado. |
| BR112019004297A2 (pt) | 2016-09-07 | 2019-05-28 | Atea Pharmaceuticals Inc | método, uso de uma quantidade eficaz de um composto, composto, e, composição farmacêutica. |
| ES2981715T3 (es) * | 2016-11-15 | 2024-10-10 | Univ Vanderbilt | Uso de 2-hidroxibencilamina en el tratamiento y la prevención de la hipertensión pulmonar |
| JP2020517721A (ja) * | 2017-04-27 | 2020-06-18 | ヴァンダービルト ユニバーシティーＶａｎｄｅｒｂｉｌｔ Ｕｎｉｖｅｒｓｉｔｙ | γ−ケトアルデヒドスカベンジャーによるアテローム性動脈硬化症の治療方法 |
| EP3678650A4 (en) * | 2017-09-05 | 2021-05-19 | MTI Biotech, Inc. | COMPOSITIONS AND METHODS OF USING GAMMA KETOALDHEYD SCAVENGERS TO TREAT, PREVENT, OR IMPROVE LIVER FIBROSIS |
| US20210023032A1 (en) * | 2017-09-05 | 2021-01-28 | Mti Biotech, Inc. | Compositions and methods of use of gamma-ketoaldheyde scavengers for treating, preventing or improving fibrosis of the liver |
| CN109836341B (zh) * | 2017-11-28 | 2021-08-27 | 江阴技源药业有限公司 | 一种水杨胺醋酸盐的制备方法 |
| US20200197323A1 (en) * | 2018-12-21 | 2020-06-25 | Vanderbilt University | Methods for suppressing accumulation of reflux-induced protein adducts |
| BR112022014876A2 (pt) * | 2020-01-27 | 2022-12-13 | Univ Vanderbilt | Sequestradores de isolevuglandinas/isocetais que têm mitocôndria como alvo e usos dos mesmos |
| CN118652245B (zh) * | 2024-08-21 | 2024-11-12 | 首都医科大学附属北京儿童医院 | 一种化合物及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3740439A (en) | 1968-06-24 | 1973-06-19 | Ciba Geigy Corp | Treating hypertension with beta-aminoalkane carboxylic acids |
| US3794734A (en) * | 1971-03-03 | 1974-02-26 | Merck & Co Inc | Methods of treating edema and hypertension using certain 2-aminoethylphenols |
| US4123537A (en) | 1977-05-26 | 1978-10-31 | Merck & Co., Inc. | 2-Halo-4-aminomethyl-6-alkyl-3-pyridinols useful as diuretics in treating hypertension and edema |
| US8178516B2 (en) * | 1992-06-30 | 2012-05-15 | Sylvan Labs, LLC | Compositions and method for treatment of chronic inflammatory diseases |
| US20050090553A1 (en) * | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
| AU5659796A (en) | 1995-05-19 | 1996-11-29 | Kissei Pharmaceutical Co. Ltd. | 2-hydroxyphenylalkylamine derivatives and maillard reaction inhibitors |
| US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
| ATE333868T1 (de) * | 2000-11-02 | 2006-08-15 | Univ South Carolina | Verwendung von pyridoxamin für die behandlung und unterdrückung von komplikationen im zusammenhang mit adipositas |
| US6824786B2 (en) | 2001-11-27 | 2004-11-30 | Ruey J. Yu | Compositions comprising phenyl-glycine derivatives |
| US7705054B1 (en) * | 2004-10-20 | 2010-04-27 | Vanderbilt University | Method of preventing and/or treating oxidant injury in neurodegenerative and oxidative diseases |
| EP2207555B1 (en) * | 2007-10-05 | 2013-07-24 | InDex Pharmaceuticals AB | Oligonucleotides for the treatment or alleviation of edema |
| KR100973343B1 (ko) * | 2008-02-01 | 2010-07-30 | 롯데칠성음료주식회사 | 기호성이 우수한 혼합차 조성물 및 그 제조방법 |
| CN101305759B (zh) * | 2008-06-19 | 2011-09-07 | 成都大学 | 一种苦荞保健茶及其制备方法 |
| CN101843671A (zh) * | 2009-03-25 | 2010-09-29 | 王文祥 | 苦荞托毒丸及其制备方法 |
| EP2477594A4 (en) * | 2009-07-15 | 2013-03-13 | Univ Vanderbilt | ISOKETAL CATCHER AND TREATMENT OF DISEASES WITH OXIDATIVE INJURY |
| CN101606986A (zh) * | 2009-07-29 | 2009-12-23 | 李钢 | 一种具有降糖作用的组合物及其药物 |
-
2012
- 2012-07-12 KR KR1020147003650A patent/KR20140050661A/ko not_active Ceased
- 2012-07-12 US US14/232,615 patent/US10975033B2/en active Active
- 2012-07-12 CN CN201280044440.6A patent/CN103796648B/zh active Active
- 2012-07-12 WO PCT/US2012/046549 patent/WO2013010034A2/en not_active Ceased
- 2012-07-12 JP JP2014520341A patent/JP6280033B2/ja active Active
- 2012-07-12 KR KR1020197016572A patent/KR102050700B1/ko active Active
- 2012-07-12 BR BR112014000810A patent/BR112014000810A8/pt not_active Application Discontinuation
- 2012-07-12 CN CN201910951171.5A patent/CN111494352A/zh active Pending
- 2012-07-12 PL PL12811030.1T patent/PL2731597T3/pl unknown
- 2012-07-12 CA CA2844150A patent/CA2844150C/en active Active
- 2012-07-12 MX MX2014000515A patent/MX383365B/es unknown
- 2012-07-12 AU AU2012281061A patent/AU2012281061B2/en active Active
- 2012-07-12 EP EP12811030.1A patent/EP2731597B1/en active Active
- 2012-07-12 HU HUE12811030A patent/HUE065757T2/hu unknown
- 2012-07-12 ES ES12811030T patent/ES2970814T3/es active Active
-
2021
- 2021-04-13 US US17/229,593 patent/US20210261508A1/en not_active Abandoned
-
2024
- 2024-10-16 US US18/917,759 patent/US20250034093A1/en active Pending
- 2024-10-16 US US18/917,789 patent/US20250214939A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6280033B2 (ja) | 2018-02-14 |
| ES2970814T3 (es) | 2024-05-30 |
| MX383365B (es) | 2025-03-13 |
| CN103796648B (zh) | 2019-10-25 |
| US10975033B2 (en) | 2021-04-13 |
| HUE065757T2 (hu) | 2024-06-28 |
| EP2731597A4 (en) | 2015-04-08 |
| US20250214939A1 (en) | 2025-07-03 |
| CA2844150A1 (en) | 2013-01-17 |
| BR112014000810A2 (pt) | 2017-06-13 |
| AU2012281061A1 (en) | 2014-02-20 |
| KR102050700B1 (ko) | 2019-11-29 |
| KR20140050661A (ko) | 2014-04-29 |
| US20210261508A1 (en) | 2021-08-26 |
| WO2013010034A3 (en) | 2013-03-28 |
| EP2731597C0 (en) | 2023-12-20 |
| CA2844150C (en) | 2019-09-03 |
| EP2731597A2 (en) | 2014-05-21 |
| EP2731597B1 (en) | 2023-12-20 |
| CN103796648A (zh) | 2014-05-14 |
| US20250034093A1 (en) | 2025-01-30 |
| BR112014000810A8 (pt) | 2022-11-29 |
| US20140256774A1 (en) | 2014-09-11 |
| KR20190069607A (ko) | 2019-06-19 |
| JP2014524918A (ja) | 2014-09-25 |
| WO2013010034A2 (en) | 2013-01-17 |
| CN111494352A (zh) | 2020-08-07 |
| AU2012281061B2 (en) | 2017-08-03 |
| MX2014000515A (es) | 2014-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE065757T2 (hu) | Eljárások gyulladás és magasvérnyomás kezelésére gamma-ketoaldehid-szkevendzserekkel | |
| EP2768443A4 (en) | METHODS AND DEVICES FOR TREATING HYPERTENSION | |
| EP2717931A4 (en) | ASSOCIATIONS AND RELATED METHODS | |
| PL2696754T3 (pl) | Urządzenie i sposób pomiaru stresu | |
| IL228212A (en) | Methods and instruments for a functional layer with a power layer | |
| EP2736330A4 (en) | COMPOUNDS AND METHODS | |
| IL230917A (en) | 1dyrk inhibitors and their uses | |
| EP2747560A4 (en) | CONNECTIONS AND METHODS | |
| EP2736332A4 (en) | CONNECTIONS AND METHODS | |
| IL234829A0 (en) | Methods and preparations for treating inflammation | |
| GB201122195D0 (en) | Composition and method | |
| PT2663864T (pt) | Método de avaliação de imunodiversidade e seu uso | |
| EP2736329A4 (en) | COMPOUNDS AND METHODS | |
| GB201408236D0 (en) | Composition and method | |
| GB201110783D0 (en) | Methods and uses | |
| EP2744275A4 (en) | METHOD AND DEVICE FOR SAVING ENERGY | |
| ZA201306848B (en) | Transverse driven-roller belt and convetor | |
| IL260077A (en) | Methods of treating excess bilirubin in the blood with stanoporfin | |
| EP2755363A4 (en) | METHOD AND DEVICE FOR FAST DATA DISTRIBUTION | |
| GB201116774D0 (en) | Uses and methods | |
| GB201112981D0 (en) | An arrangement and method | |
| GB201101862D0 (en) | Method and device | |
| GB201106433D0 (en) | Composition and method | |
| ZA201308807B (en) | Hypertension and hyperuricemia | |
| GB201112970D0 (en) | An arrangement and method |